PB Fintech Limited Independent Directors Conclude Terms

PB Fintech Limited announced that two of its Independent Directors, Mr. Kaushik Dutta and Ms. Lilian Jessie Paul, have completed their first terms on June 18, 2026. Due to current professional and personal commitments, they have opted not to seek reappointment. Consequently, both directors have ceased their roles, effective from the close of business hours on the aforementioned date. The company expressed gratitude for their contributions.

Director Departures Announced

PB Fintech Limited has officially informed the stock exchanges that two of its Independent Directors, Mr. Kaushik Dutta (DIN: 03328890) and Ms. Lilian Jessie Paul (DIN: 02864506), have concluded their initial terms of office on June 18, 2026. The company confirmed that both directors have decided not to seek reappointment for a second term, citing current professional preoccupations and personal commitments.

Impact on Board Committees

As a result of their departure, Mr. Kaushik Dutta has stepped down from his position as the Chairperson of the Audit Committee and as a Member of the M&A and Investment Committee. Concurrently, Ms. Lilian Jessie Paul has ceased her roles as a Member of the Stakeholders’ Relationship Committee and the Corporate Social Responsibility Committee. These changes are effective from the close of business on June 18, 2026.

Appreciation for Service

The Board of Directors and the Management of PB Fintech Limited have extended their sincere appreciation for the valuable contributions, guidance, and services provided by Mr. Kaushik Dutta and Ms. Lilian Jessie Paul during their tenure as Independent Directors of the Company. Their insights and leadership were instrumental during their association with the firm.

Disclosures Provided

The company has provided detailed disclosures as required by the relevant regulations, outlining the reasons for the change in directorships and related information. These disclosures are enclosed as per the regulatory guidelines.

Source: BSE

Previous Article

Cholamandalam Investment and Finance Company Limited Compliance Certificate for Secured Non-Convertible Securities

Next Article

Jubilant Pharmova USFDA Completes Inspection of Contract Manufacturing Facility